Colfax announces fourth quarter 2020 results and 2021 growth outlook

•         reported $0.29 eps from continuing operations and achieved $0.51 of adjusted eps•         recently acquired two high-growth, high-gross margin medical technology businesses  •         announced 2021 outlook with expectations for significant revenue, profit and cash flow growth •         scheduled investor day for thursday, march 11, 2021
CFX Ratings Summary
CFX Quant Ranking